115 related articles for article (PubMed ID: 22112493)
1. Bioinformatics: biomarkers of early detection.
Crichton DJ; Mattmann CA; Thornquist M; Anton K; Hughes JS
Cancer Biomark; 2010; 9(1-6):511-30. PubMed ID: 22112493
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics: Tools to accelerate population science and disease control research.
Forman MR; Greene SM; Avis NE; Taplin SH; Courtney P; Schad PA; Hesse BW; Winn DM
Am J Prev Med; 2010 Jun; 38(6):646-51. PubMed ID: 20494241
[TBL] [Abstract][Full Text] [Related]
3. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
4. Systematic, evidence-based discovery of biomarkers at the NCI.
Prensner JR; Chinnaiyan AM; Srivastava S
Clin Exp Metastasis; 2012 Oct; 29(7):645-52. PubMed ID: 22868876
[TBL] [Abstract][Full Text] [Related]
5. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
6. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers.
Srivastava S; Wagner PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2401-2410. PubMed ID: 32357955
[TBL] [Abstract][Full Text] [Related]
7. The early detection research network: 10-year outlook.
Srivastava S
Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
[TBL] [Abstract][Full Text] [Related]
8. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
9. Proteome informatics for cancer research: from molecules to clinic.
Brusic V; Marina O; Wu CJ; Reinherz EL
Proteomics; 2007 Mar; 7(6):976-91. PubMed ID: 17370257
[TBL] [Abstract][Full Text] [Related]
10. From space to biomedicine: Enabling biomarker data science in the cloud.
Crichton DJ; Cinquini L; Kincaid H; Mahabal A; Altinok A; Anton K; Colbert M; Kelly S; Liu D; Patriotis C; Lombeyda S; Srivastava S
Cancer Biomark; 2022; 33(4):479-488. PubMed ID: 35491772
[TBL] [Abstract][Full Text] [Related]
11. The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.
Kammer MN; Deppen SA; Antic S; Jamshedur Rahman SM; Eisenberg R; Maldonado F; Aldrich MC; Sandler KL; Landman B; Massion PP; Grogan EL
Cancer Biomark; 2022; 33(4):449-465. PubMed ID: 35491773
[TBL] [Abstract][Full Text] [Related]
12. Biomedical informatics research network: building a national collaboratory to hasten the derivation of new understanding and treatment of disease.
Grethe JS; Baru C; Gupta A; James M; Ludaescher B; Martone ME; Papadopoulos PM; Peltier ST; Rajasekar A; Santini S; Zaslavsky IN; Ellisman MH
Stud Health Technol Inform; 2005; 112():100-9. PubMed ID: 15923720
[TBL] [Abstract][Full Text] [Related]
13. Adding Rigor to Biomarker Evaluations-EDRN Experience.
Feng Z; Pepe MS
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2575-2582. PubMed ID: 33172885
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Dancey JE; Dobbin KK; Groshen S; Jessup JM; Hruszkewycz AH; Koehler M; Parchment R; Ratain MJ; Shankar LK; Stadler WM; True LD; Gravell A; Grever MR;
Clin Cancer Res; 2010 Mar; 16(6):1745-55. PubMed ID: 20215558
[TBL] [Abstract][Full Text] [Related]
15. Strategic approach to validating methylated genes as biomarkers for breast cancer.
Wang W; Srivastava S
Cancer Prev Res (Phila); 2010 Jan; 3(1):16-24. PubMed ID: 20051369
[TBL] [Abstract][Full Text] [Related]
16. An NCI perspective on creating sustainable biospecimen resources.
Vaught J; Rogers J; Myers K; Lim MD; Lockhart N; Moore H; Sawyer S; Furman JL; Compton C
J Natl Cancer Inst Monogr; 2011; 2011(42):1-7. PubMed ID: 21672889
[TBL] [Abstract][Full Text] [Related]
17. [caCORE: core architecture of bioinformation on cancer research in America].
Gao Q; Zhang YL; Xie ZY; Zhang QP; Hu ZZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):218-21. PubMed ID: 16617371
[TBL] [Abstract][Full Text] [Related]
18. Semantic data integration and knowledge management to represent biological network associations.
Losko S; Heumann K
Methods Mol Biol; 2009; 563():241-58. PubMed ID: 19597789
[TBL] [Abstract][Full Text] [Related]
19. Small molecules, big players: the National Cancer Institute's Initiative for Chemical Genetics.
Tolliday N; Clemons PA; Ferraiolo P; Koehler AN; Lewis TA; Li X; Schreiber SL; Gerhard DS; Eliasof S
Cancer Res; 2006 Sep; 66(18):8935-42. PubMed ID: 16982730
[TBL] [Abstract][Full Text] [Related]
20. Standards in molecular diagnostics for the discovery and validation of clinically useful cancer biomarkers.
Vydelingum NA; Sorbara L; Wagner P; Srivastava S
Expert Rev Mol Diagn; 2013 Jun; 13(5):421-3. PubMed ID: 23782249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
